Reata Pharmaceuticals
RETA
$172.36
Share price
0.00%
Change (1 day)
373.78%
Change (1 year)
Categories
Earnings for Reata Pharmaceuticals (RETA)
Earnings in 2023 (TTM): -$52.42 M
According to Reata Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$52.42 M. In 2022 the company made an earning of -$0.28 B a decrease over its 2021 earnings that were of -$0.25 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Reata Pharmaceuticals from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$52.42 M | -80.65% |
| 2022 | -$0.28 B | 10.73% |
| 2021 | -$0.25 B | 4.11% |
| 2020 | -$0.24 B | -16.21% |
| 2019 | -$0.29 B | 277.17% |
| 2018 | -$74.35 M | 60.87% |
| 2017 | -$46.22 M | 571.51% |
| 2016 | -$6.89 M | 1960.48% |
| 2015 | -$0.34 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 111.33% | 🇺🇸 USA |